SI3539961T1 - Derivati policikličnih amidov kot zaviralci CDK9 - Google Patents

Derivati policikličnih amidov kot zaviralci CDK9

Info

Publication number: SI3539961T1
Authority: SI; Slovenia
Prior art keywords: amide derivatives; cdk9 inhibitors; polycyclic amide; polycyclic; cdk9
Prior art date: 2015-06-29

Application number

SI201631427T

Other languages

English (en)

Inventor

Kurt Gordon Pike

Bernard Christophe Barlaam

Janet Hawkins

Savi Christopher De

Melissa Marie Vasbinder

Alexander Hird

Michelle Lamb

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-06-29

Filing date

2016-06-27

Publication date

2022-02-28

2016-06-27 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2022-02-28 Publication of SI3539961T1 publication Critical patent/SI3539961T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polyesters Or Polycarbonates (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Detergent Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SI201631427T 2015-06-29 2016-06-27 Derivati policikličnih amidov kot zaviralci CDK9 SI3539961T1 (sl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201562185852P	2015-06-29	2015-06-29
EP19165726.1A EP3539961B1 (en)	2015-06-29	2016-06-27	Polycyclic amide derivatives as cdk9 inhibitors

Publications (1)

Publication Number	Publication Date
SI3539961T1 true SI3539961T1 (sl)	2022-02-28

Family

ID=56292699

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI201630247T SI3313838T1 (sl)	2015-06-29	2016-06-27	Derivati policikličnega amida kot inhibitorji CDK9
SI201631427T SI3539961T1 (sl)	2015-06-29	2016-06-27	Derivati policikličnih amidov kot zaviralci CDK9

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SI201630247T SI3313838T1 (sl)	2015-06-29	2016-06-27	Derivati policikličnega amida kot inhibitorji CDK9

Country Status (38)

Country	Link
US (4)	US9845331B2 (sl)
EP (2)	EP3313838B1 (sl)
JP (1)	JP6997627B2 (sl)
KR (1)	KR102663113B1 (sl)
CN (1)	CN107873028B (sl)
AR (1)	AR105179A1 (sl)
AU (1)	AU2016286200B2 (sl)
BR (1)	BR122019013677B1 (sl)
CA (1)	CA2989499C (sl)
CL (1)	CL2017003306A1 (sl)
CO (1)	CO2017013713A2 (sl)
CR (2)	CR20210297A (sl)
CY (2)	CY1122111T1 (sl)
DK (2)	DK3313838T3 (sl)
DO (2)	DOP2017000295A (sl)
EA (1)	EA035383B1 (sl)
ES (2)	ES2902148T3 (sl)
HR (2)	HRP20211970T1 (sl)
HU (2)	HUE057343T2 (sl)
IL (1)	IL256393B (sl)
LT (2)	LT3539961T (sl)
ME (1)	ME03404B (sl)
MX (1)	MX371034B (sl)
MY (1)	MY201673A (sl)
NI (1)	NI201700174A (sl)
PE (1)	PE20180530A1 (sl)
PH (1)	PH12017502334B1 (sl)
PL (2)	PL3539961T3 (sl)
PT (2)	PT3313838T (sl)
RS (2)	RS62781B1 (sl)
SI (2)	SI3313838T1 (sl)
SM (2)	SMT202200005T1 (sl)
SV (1)	SV2017005598A (sl)
TN (1)	TN2017000486A1 (sl)
TR (1)	TR201909286T4 (sl)
TW (1)	TWI723028B (sl)
WO (1)	WO2017001354A1 (sl)
ZA (1)	ZA201800563B (sl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2020003270A (es)	2017-09-25	2020-07-20	Astrazeneca Ab	Combinacion de un inhibidor de btk y un inhibidor de cdk9 para tratar el cancer.
EP3694506B1 (en) *	2017-10-09	2023-08-02	Merck Sharp & Dohme LLC	Novel substituted phenyloxetane and phenyltetrahydrofuran compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
CN108129288B (zh) *	2017-12-27	2021-01-22	上海毕得医药科技股份有限公司	一种反式-3-羟基环丁基甲酸的合成方法
TWI810397B (zh)	2018-11-14	2023-08-01	瑞典商阿斯特捷利康公司	治療癌症之方法
CN114008046B (zh) *	2019-06-27	2023-08-18	南京明德新药研发有限公司	作为cdk9抑制剂的氮杂吲哚连吡唑类化合物
EP4028005A4 (en) *	2019-09-11	2023-09-20	Prelude Therapeutics, Incorporated	Cdk inhibitors and their use as pharmaceuticals
US20230102081A1 (en) *	2019-12-09	2023-03-30	Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.	Compound as cyclin-dependent kinase 9 inhibitor and use thereof
EP4140997A4 (en) *	2020-05-12	2023-09-06	Suzhou Alphama Biotechnology Co., Ltd.	PYRIDINE ACETAMIDE DERIVATIVE AS CDK INHIBITOR, PREPARATION METHOD AND USE THEREOF
CN113149996B (zh) *	2020-05-12	2022-12-20	苏州阿尔脉生物科技有限公司	一种作为cdk9抑制剂的多环酰胺类衍生物、其制备方法及用途
CN116615248A (zh) *	2020-06-24	2023-08-18	阿斯利康(英国)有限公司	抗体-药物缀合物和cdk9抑制剂的组合
CN115843296B (zh)	2020-08-07	2024-03-08	南京迈晟科技有限责任公司	Cdk9抑制剂及其用途
TWI809330B (zh) *	2020-11-20	2023-07-21	大陸商勁方醫藥科技(上海)有限公司	Cdk9抑制劑的多晶型物及其製法和用途
WO2022247796A1 (zh) *	2021-05-24	2022-12-01	石药集团中奇制药技术（石家庄）有限公司	周期蛋白依赖性激酶9抑制剂的用途
CN115381823B (zh) *	2021-05-24	2024-11-05	石药集团中奇制药技术（石家庄）有限公司	一种周期蛋白依赖性激酶9抑制剂的用途
WO2023284775A1 (zh) *	2021-07-14	2023-01-19	上海海雁医药科技有限公司	吡唑衍生物及其中间体和制备方法
CN115703738B (zh) *	2021-08-16	2024-06-21	中国科学院上海药物研究所	含2-芳杂环取代的脲类化合物、其制备方法和用途
MX2024007929A (es) *	2021-12-23	2024-09-10	Univ Leuven Kath	Tetrahidropirazolopirimidinas y analogos relacionados para la inhibicion de yap/taz-tead.
JP2025528223A (ja)	2022-08-17	2025-08-26	コリアリサーチインスティテュートオブケミカルテクノロジー	Ｃｄｋ２及び／又はｃｄｋ９の抑制又は分解用化合物及びこれらの医薬用途
AU2024258350A1 (en) *	2023-04-19	2025-10-30	Alcon Inc.	N-substituted c6 cyclyl carboxamide compounds and uses thereof
WO2025076115A1 (en) *	2023-10-02	2025-04-10	Prelude Therapeutics Incorporated	Cdk inhibitors and their use as pharmaceuticals

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008133192A1 (ja)	2007-04-19	2008-11-06	Takeda Pharmaceutical Company Limited	縮合イミダゾール化合物およびその用途
WO2008129069A1 (en)	2007-04-24	2008-10-30	Ingenium Pharmaceuticals Gmbh	Inhibitors of protein kinases
US8436007B2 (en)	2007-04-24	2013-05-07	Ingenium Pharmaceuticals Gmbh	Inhibitors of protein kinases
US8507498B2 (en)	2007-04-24	2013-08-13	Ingenium Pharmaceuticals Gmbh	4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
WO2008129071A1 (en)	2007-04-24	2008-10-30	Ingenium Pharmaceuticals Gmbh	Inhibitors of protein kinases
WO2008132138A1 (en)	2007-04-25	2008-11-06	Ingenium Pharmaceuticals Gmbh	Derivatives of 4,6-disubstituted aminopyrimidines
NZ584454A (en)	2007-10-12	2011-09-30	Ingenium Pharmaceuticals Gmbh	N-[6-phenyl-pyrimidin-4-yl]-amides and urea derivatives as inhibitors of protein kinases
EP2473502A1 (en)	2009-09-04	2012-07-11	Novartis AG	Heteroaryl compounds as kinase inhibitors
US20110113038A1 (en)	2009-11-12	2011-05-12	International Business Machines Corporation	Search term security
GB201002911D0 (en)	2010-02-19	2010-04-07	Medical Res Council	Compound
NZ627520A (en)	2010-03-10	2015-10-30	Astrazeneca Ab	4-phenyl pyridine analogues as protein kinase inhibitors
AR081810A1 (es) *	2010-04-07	2012-10-24	Bayer Cropscience Ag	Piridinilpirazoles biciclicos
WO2012066065A1 (en)	2010-11-17	2012-05-24	Novartis Ag	Phenyl-heteroaryl amine compounds and their uses
JP2014506878A (ja) *	2011-01-28	2014-03-20	ノバルティスアーゲー	Ｃｄｋ９阻害剤としての置換ビ−ヘテロアリール化合物およびそれらの使用
WO2012101064A1 (en) *	2011-01-28	2012-08-02	Novartis Ag	N-acyl pyrimidine biaryl compounds as protein kinase inhibitors
WO2012101063A1 (en) *	2011-01-28	2012-08-02	Novartis Ag	N-acyl pyridine biaryl compounds and their uses
US9314026B2 (en)	2011-10-06	2016-04-19	Bayer Intellectual Property Gmbh	Heterocyclylpyri(mi)dinylpyrazole
EP2970200A1 (en)	2013-03-13	2016-01-20	Abbvie Inc.	Pyridine cdk9 kinase inhibitors
JP2016512559A (ja)	2013-03-13	2016-04-28	アッヴィ・インコーポレイテッド	Ｃｄｋ９キナーゼ阻害薬
UY35419A (es)	2013-03-14	2014-10-31	Abbvie Inc	Inhibidores de cdk9 quinasa de pirrolo (2,3- b) piridina
CA2903538A1 (en)	2013-03-14	2014-10-02	Abbvie Inc.	Pyrrolopyrimindine cdk9 kinase inhibitors

2016
- 2016-06-27 PH PH1/2017/502334A patent/PH12017502334B1/en unknown
- 2016-06-27 SI SI201630247T patent/SI3313838T1/sl unknown
- 2016-06-27 PL PL19165726T patent/PL3539961T3/pl unknown
- 2016-06-27 TN TNP/2017/000486A patent/TN2017000486A1/en unknown
- 2016-06-27 ES ES19165726T patent/ES2902148T3/es active Active
- 2016-06-27 EP EP16733459.8A patent/EP3313838B1/en active Active
- 2016-06-27 PE PE2017002874A patent/PE20180530A1/es unknown
- 2016-06-27 SI SI201631427T patent/SI3539961T1/sl unknown
- 2016-06-27 EP EP19165726.1A patent/EP3539961B1/en active Active
- 2016-06-27 ES ES16733459T patent/ES2728356T3/es active Active
- 2016-06-27 HR HRP20211970TT patent/HRP20211970T1/hr unknown
- 2016-06-27 PT PT16733459T patent/PT3313838T/pt unknown
- 2016-06-27 HU HUE19165726A patent/HUE057343T2/hu unknown
- 2016-06-27 RS RS20220005A patent/RS62781B1/sr unknown
- 2016-06-27 BR BR122019013677-7A patent/BR122019013677B1/pt active IP Right Grant
- 2016-06-27 MX MX2017016244A patent/MX371034B/es active IP Right Grant
- 2016-06-27 EA EA201890094A patent/EA035383B1/ru not_active IP Right Cessation
- 2016-06-27 US US15/193,826 patent/US9845331B2/en active Active
- 2016-06-27 DK DK16733459.8T patent/DK3313838T3/da active
- 2016-06-27 LT LTEP19165726.1T patent/LT3539961T/lt unknown
- 2016-06-27 CR CR20210297A patent/CR20210297A/es unknown
- 2016-06-27 WO PCT/EP2016/064899 patent/WO2017001354A1/en not_active Ceased
- 2016-06-27 LT LTEP16733459.8T patent/LT3313838T/lt unknown
- 2016-06-27 CA CA2989499A patent/CA2989499C/en active Active
- 2016-06-27 RS RS20190564A patent/RS58712B1/sr unknown
- 2016-06-27 PT PT191657261T patent/PT3539961T/pt unknown
- 2016-06-27 CN CN201680029447.9A patent/CN107873028B/zh active Active
- 2016-06-27 MY MYPI2017705054A patent/MY201673A/en unknown
- 2016-06-27 CR CR20170596A patent/CR20170596A/es unknown
- 2016-06-27 SM SM20220005T patent/SMT202200005T1/it unknown
- 2016-06-27 SM SM20190298T patent/SMT201900298T1/it unknown
- 2016-06-27 AU AU2016286200A patent/AU2016286200B2/en active Active
- 2016-06-27 ME MEP-2019-138A patent/ME03404B/me unknown
- 2016-06-27 KR KR1020187002262A patent/KR102663113B1/ko active Active
- 2016-06-27 JP JP2017567737A patent/JP6997627B2/ja active Active
- 2016-06-27 TR TR2019/09286T patent/TR201909286T4/tr unknown
- 2016-06-27 PL PL16733459T patent/PL3313838T3/pl unknown
- 2016-06-27 DK DK19165726.1T patent/DK3539961T3/da active
- 2016-06-27 HU HUE16733459A patent/HUE043440T2/hu unknown
- 2016-06-27 HR HRP20190748TT patent/HRP20190748T1/hr unknown
- 2016-06-28 TW TW105120362A patent/TWI723028B/zh active
- 2016-06-28 AR ARP160101956A patent/AR105179A1/es unknown
2017
- 2017-12-06 US US15/833,277 patent/US10717746B2/en active Active
- 2017-12-12 DO DO2017000295A patent/DOP2017000295A/es unknown
- 2017-12-18 IL IL256393A patent/IL256393B/en unknown
- 2017-12-20 SV SV2017005598A patent/SV2017005598A/es unknown
- 2017-12-21 CL CL2017003306A patent/CL2017003306A1/es unknown
- 2017-12-22 NI NI201700174A patent/NI201700174A/es unknown
- 2017-12-28 CO CONC2017/0013713A patent/CO2017013713A2/es unknown
2018
- 2018-01-26 ZA ZA2018/00563A patent/ZA201800563B/en unknown
- 2018-09-25 DO DO2018000207A patent/DOP2018000207A/es unknown
2019
- 2019-06-19 CY CY20191100636T patent/CY1122111T1/el unknown
2020
- 2020-07-17 US US16/931,786 patent/US11352369B2/en active Active
2021
- 2021-12-22 CY CY20211101125T patent/CY1125066T1/el unknown
2022
- 2022-04-27 US US17/660,935 patent/US20220340592A1/en active Pending

Also Published As

Publication number	Publication date
CY1122111T1 (el)	2020-11-25
LT3539961T (lt)	2021-12-27
ME03404B (me)	2020-01-20
BR112017027394A2 (pt)	2018-11-06
TWI723028B (zh)	2021-04-01
ZA201800563B (en)	2022-08-31
US9845331B2 (en)	2017-12-19
DOP2017000295A (es)	2017-12-31
EP3313838B1 (en)	2019-04-03
KR20180021830A (ko)	2018-03-05
US20160376287A1 (en)	2016-12-29
AU2016286200B2 (en)	2018-10-04
SV2017005598A (es)	2018-02-23
JP6997627B2 (ja)	2022-01-17
TR201909286T4 (tr)	2019-07-22
SMT202200005T1 (it)	2022-03-21
TW201718573A (zh)	2017-06-01
US20210171541A1 (en)	2021-06-10
CR20170596A (es)	2018-07-04
PT3539961T (pt)	2021-12-20
EP3539961A1 (en)	2019-09-18
CY1125066T1 (el)	2023-03-24
MX371034B (es)	2020-01-13
HRP20211970T1 (hr)	2022-03-18
DK3313838T3 (da)	2019-06-11
PH12017502334B1 (en)	2023-05-26
PT3313838T (pt)	2019-06-24
ES2728356T3 (es)	2019-10-23
PL3539961T3 (pl)	2022-02-14
JP2018522869A (ja)	2018-08-16
MY201673A (en)	2024-03-12
SI3313838T1 (sl)	2019-06-28
CN107873028A (zh)	2018-04-03
RS62781B1 (sr)	2022-01-31
SMT201900298T1 (it)	2019-07-11
ES2902148T3 (es)	2022-03-25
TN2017000486A1 (en)	2019-04-12
WO2017001354A1 (en)	2017-01-05
PL3313838T3 (pl)	2019-08-30
US10717746B2 (en)	2020-07-21
RS58712B1 (sr)	2019-06-28
CA2989499C (en)	2023-10-31
PE20180530A1 (es)	2018-03-19
US20220340592A1 (en)	2022-10-27
HUE057343T2 (hu)	2022-05-28
NI201700174A (es)	2018-10-19
HRP20190748T1 (hr)	2019-06-14
HUE043440T2 (hu)	2019-08-28
CA2989499A1 (en)	2017-01-05
AR105179A1 (es)	2017-09-13
EP3539961B1 (en)	2021-10-06
MX2017016244A (es)	2018-04-20
US20180093998A1 (en)	2018-04-05
LT3313838T (lt)	2019-06-10
PH12017502334A1 (en)	2018-06-25
EA201890094A1 (ru)	2018-07-31
CR20210297A (es)	2021-09-29
DK3539961T3 (da)	2022-01-03
CO2017013713A2 (es)	2018-03-28
EA035383B1 (ru)	2020-06-04
EP3313838A1 (en)	2018-05-02
IL256393B (en)	2021-12-01
CN107873028B (zh)	2021-02-02
AU2016286200A1 (en)	2018-02-08
KR102663113B1 (ko)	2024-05-02
CL2017003306A1 (es)	2018-06-29
BR122019013677B1 (pt)	2024-01-02
IL256393A (en)	2018-02-28
US11352369B2 (en)	2022-06-07
DOP2018000207A (es)	2018-10-15

Publication	Publication Date	Title
SI3539961T1 (sl)	2022-02-28	Derivati policikličnih amidov kot zaviralci CDK9
CY2024003I2 (el)	2024-09-20	Ενωσεις χρησιμες ως αναστολεις κινασης
SI3786162T1 (sl)	2024-02-29	Bipirazolni derivati kot zaviralci JAK
LT3436461T (lt)	2024-03-12	Pirolotriazino junginiai kaip tam inhibitoriai
DK3319956T3 (da)	2021-03-29	Substituerede oxopyridinderivater
HRP20182073T1 (hr)	2019-02-08	Derivati kinoksalina korisni kao modulatori fgfr kinaze
HRP20181650T1 (hr)	2018-12-14	Biciklički heterociklički derivati kao inhibitori bromodomene
DK3428170T3 (da)	2021-03-01	Anti-influenza polycyklisk pyridonderivat og prodrug deraf
HRP20192197T8 (hr)	2020-04-03	Derivati karbazola
SI3457851T1 (sl)	2022-04-29	Derivati sobetiroma
LT3386991T (lt)	2020-08-25	Policikliniai junginiai, kaip brutono tirozinkinazės inhibitoriai
DK3544981T3 (da)	2021-09-20	Benzodiazoliumforbindelser som enac-inhibitorer
HRP20190127T1 (hr)	2019-03-22	Derivati pirolidinona kao inhibitori metap-2
HRP20190336T1 (hr)	2019-05-03	Derivati 6-alkinilpiridina kao smac-mimetici
EP3309163A4 (en)	2019-01-09	SUBSTITUTED DIHYDROPYRROLO PYRAZOL DERIVATIVE
EP3615525C0 (en)	2024-12-25	PYRROLE DERIVATIVES AS PLK1 INHIBITORS
SMT202200201T1 (it)	2022-07-21	Derivati di tetraidroisochinolina
EP3444345C0 (en)	2024-07-10	MICRO-143 RNA DERIVATIVE
LT3319970T (lt)	2019-11-11	Pirido-oksazinono dariniai kaip tnap inhibitoriai
HRP20182016T1 (hr)	2019-01-25	Derivati etinila
HRP20181112T1 (hr)	2018-09-21	Supstituirani derivati azaspiro(4,5)dekana
SI3484875T1 (sl)	2021-08-31	Derivati pirazolilaminobenzimidazola kot zaviralci JAK
SI3303316T1 (sl)	2020-07-31	Derivati etinila
ITUA20162785A1 (it)	2017-10-21	Antifumo per bitume e suoi derivati
TH1601003052A (th)	2017-07-20	อนุพันธ์เอไมด์ สำหรับ gpr119 อะโกนิสต์